Our Network AstraZeneca announces collaboration and investment agreement with Cellectis to accelerate cell therapy and genomic medicine ambitions Tags: #Research #Oncology #Medical Oncology #Partnership #AstraZeneca #Rare disease Collaboration leverages the Cellectis gene editing technologies and manufacturing capabilities, to develop up to 10 novel cell and gene therapy candidate products.
